Home › Trial NCT04314219
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
- Trial IDNCT04314219
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorKing Faisal Specialist Hospital & Research Center
- Enrollment264
- Start date2021-08-15
- ConditionsAcute Lymphoblastic Leukemia (ALL) in Complete Remission · Acute Myeloid Leukemia (AML) in Remission
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.